Meridian Clinical Research, LLC

Lincoln, Nebraska 68510

0 studies enrolling now · 7 studies all time

What they study most

Acute Migraine With or Without Aura, Asthma, COVID-19, COVID-19 Disease, Human Metapneumovirus and Human Parainfluenza Infection, Influenza, Human, Influenza, Human Prevention, Respiratory Syncytial Viruses Prevention

Studies at this site

• Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults ≥50 Years of Age — Completed
• A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19 — Completed
• A Comparison of PT027 vs PT007 Used as Needed in Participants With Asthma — Completed
• A Study of an Ad26.RSV.preF-based Vaccine and High-dose Seasonal Influenza Vaccine, With and Without Coadministration, in Adults Aged 65 Years and Older — Completed
• ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2 — Completed
• Study to Assess the Safety and Efficacy of ONZETRA® Xsail® for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents — Stopped early
• Safety and Immunogenicity of mRNA-1653, a Combined Human Metapneumovirus (hMPV) and Parainfluenza Virus Type 3 (PIV3) Vaccine, in Healthy Adults, and Children 12 to 59 Months of Age With Serologic Evidence of Prior Exposure — Completed